The designation LOC145837 Activators suggests a category of molecular entities that would interact with the product of a genomic sequence identified as LOC145837. In genomic nomenclature, LOC followed by a series of numbers typically points to a specific genomic locus that has been annotated but may not have a fully characterized function. The numeric sequence serves as a unique identifier, allowing researchers to reference and investigate the locus within genetic databases. Without a clear, established understanding of the functional biology of LOC145837, the chemical class of its activators remains a conceptual framework rather than a defined group of compounds. Nonetheless, if one were to engage in the design of such activators, the process would involve a detailed exploration of the locus, including the study of its expression patterns, the biological role of its protein product (if any), and the regulatory pathways it might be involved in.
In the scenario where activators for LOC145837 are under investigation, the development process would encompass several stages. Researchers would first aim to elucidate the structure of the protein encoded by LOC145837 using advanced techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, or cryo-electron microscopy. This structural insight would be crucial to identify potential binding sites for activator molecules. Following this, a combination of computational modeling and high-throughput chemical screening would be employed to identify lead compounds with potential activating properties. These molecules would be tested in various biochemical assays to assess their ability to modulate the activity of the protein product of LOC145837. Through an iterative process of molecular modification and optimization, chemists would refine the lead molecules, enhancing their potency, selectivity, and stability to interact effectively with the protein of interest, thereby increasing its biological activity. Such endeavors would rely heavily on a multidisciplinary approach, integrating the efforts of molecular biologists, chemists, and bioinformaticians to translate the genomic information of LOC145837 into a tangible set of activator compounds.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
It is a phytoestrogen that may act as an epigenetic modifier, potentially restoring the expression of genes downregulated in cancer. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
As an HDAC inhibitor, it might increase the expression of tumor suppressor genes that are commonly silenced in cancer. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
This compound has been shown to affect multiple signaling pathways and might upregulate tumor suppressor gene expression. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
It can modify the acetylation status of histones and might lead to the re-expression of genes silenced in cancer cells. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
A chemotherapeutic agent that can induce thymineless death and might modulate the expression of certain genes involved in cell migration. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This DNA methyltransferase inhibitor could reactivate tumor suppressor genes that are silenced by hypermethylation in cancer. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
As an HDAC inhibitor, it could increase the expression of genes that are downregulated in cancer due to epigenetic silencing. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
It may modulate multiple signaling pathways and has been suggested to affect gene expression related to cancer progression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
A derivative of vitamin A that regulates gene expression and might induce the expression of genes involved in cell differentiation. | ||||||
Caffeic acid phenethyl ester | 104594-70-9 | sc-200800 sc-200800A sc-200800B | 20 mg 100 mg 1 g | $71.00 $296.00 $612.00 | 19 | |
It is an active component of propolis with potential epigenetic modulating activity, which could restore normal gene expression patterns. | ||||||